Current Opinion in Investigational Drugs via MedWorm.com MedWorm.com provides a medical RSS filtering service. Over 6000 RSS medical sources are combined and output via different filters. This feed contains the latest items from the 'Current Opinion in Investigational Drugs' source. Sat, 29 Jan 2011 15:32:28 +0100 Reporting disease control rates or clinical benefit rates in early clinical trials of anticancer agents: Useful endpoint or hype? http://www.medworm.com/index.php?rid=4400999&cid=s_34061_13_f&fid=34061&url=http%3A%2F%2Fwww.biomedcentral.com%2Fcurropininvestigdrugs%2F No description available (Source: Current Opinion in Investigational Drugs) Current Opinion in Investigational Drugs journals http://www.medworm.com/rss/comments.php?id=4400999 Tue, 30 Nov 2010 00:00:00 +0100 4400999 Pharmacological inhibition of TGFI^2 as a strategy to augment the antitumor immune response http://www.medworm.com/index.php?rid=4400998&cid=s_34061_13_f&fid=34061&url=http%3A%2F%2Fwww.biomedcentral.com%2Fcurropininvestigdrugs%2F No description available (Source: Current Opinion in Investigational Drugs) Current Opinion in Investigational Drugs journals http://www.medworm.com/rss/comments.php?id=4400998 Tue, 30 Nov 2010 00:00:00 +0100 4400998 Clinical development of mAbs to block the PD1 pathway as an immunotherapy for cancer http://www.medworm.com/index.php?rid=4400997&cid=s_34061_13_f&fid=34061&url=http%3A%2F%2Fwww.biomedcentral.com%2Fcurropininvestigdrugs%2F No description available (Source: Current Opinion in Investigational Drugs) Current Opinion in Investigational Drugs journals http://www.medworm.com/rss/comments.php?id=4400997 Tue, 30 Nov 2010 00:00:00 +0100 4400997 Intracellular amino acid sensing and mTORC1-regulated growth: New ways to block an old target? http://www.medworm.com/index.php?rid=4400996&cid=s_34061_13_f&fid=34061&url=http%3A%2F%2Fwww.biomedcentral.com%2Fcurropininvestigdrugs%2F No description available (Source: Current Opinion in Investigational Drugs) Current Opinion in Investigational Drugs journals http://www.medworm.com/rss/comments.php?id=4400996 Tue, 30 Nov 2010 00:00:00 +0100 4400996 Gene therapy for HCV/HBV-induced hepatocellular carcinoma http://www.medworm.com/index.php?rid=4400995&cid=s_34061_13_f&fid=34061&url=http%3A%2F%2Fwww.biomedcentral.com%2Fcurropininvestigdrugs%2F No description available (Source: Current Opinion in Investigational Drugs) Current Opinion in Investigational Drugs journals http://www.medworm.com/rss/comments.php?id=4400995 Tue, 30 Nov 2010 00:00:00 +0100 4400995 Anti-GITR antibodies - Potential clinical applications for tumor immunotherapy http://www.medworm.com/index.php?rid=4400994&cid=s_34061_13_f&fid=34061&url=http%3A%2F%2Fwww.biomedcentral.com%2Fcurropininvestigdrugs%2F No description available (Source: Current Opinion in Investigational Drugs) Current Opinion in Investigational Drugs journals http://www.medworm.com/rss/comments.php?id=4400994 Tue, 30 Nov 2010 00:00:00 +0100 4400994 Agents targeting the Hedgehog pathway for pancreatic cancer treatment http://www.medworm.com/index.php?rid=4400993&cid=s_34061_13_f&fid=34061&url=http%3A%2F%2Fwww.biomedcentral.com%2Fcurropininvestigdrugs%2F No description available (Source: Current Opinion in Investigational Drugs) Current Opinion in Investigational Drugs journals http://www.medworm.com/rss/comments.php?id=4400993 Tue, 30 Nov 2010 00:00:00 +0100 4400993 New approaches to the development of adenoviral dendritic cell vaccines in melanoma http://www.medworm.com/index.php?rid=4400992&cid=s_34061_13_f&fid=34061&url=http%3A%2F%2Fwww.biomedcentral.com%2Fcurropininvestigdrugs%2F No description available (Source: Current Opinion in Investigational Drugs) Current Opinion in Investigational Drugs journals http://www.medworm.com/rss/comments.php?id=4400992 Tue, 30 Nov 2010 00:00:00 +0100 4400992 Subject Index - Volume 11 http://www.medworm.com/index.php?rid=4400991&cid=s_34061_13_f&fid=34061&url=http%3A%2F%2Fwww.biomedcentral.com%2Fcurropininvestigdrugs%2F No description available (Source: Current Opinion in Investigational Drugs) Current Opinion in Investigational Drugs journals http://www.medworm.com/rss/comments.php?id=4400991 Tue, 30 Nov 2010 00:00:00 +0100 4400991 Abating progressive tissue injury and preserving function after CNS trauma: The role of inflammation modulatory therapies http://www.medworm.com/index.php?rid=4110284&cid=s_34061_13_f&fid=34061&url=http%3A%2F%2Fwww.biomedcentral.com%2Fcurropininvestigdrugs%2F No description available (Source: Current Opinion in Investigational Drugs) Current Opinion in Investigational Drugs journals http://www.medworm.com/rss/comments.php?id=4110284 Sun, 24 Oct 2010 23:00:00 +0100 4110284 Targeting the IL-1 family members in skin inflammation http://www.medworm.com/index.php?rid=4110283&cid=s_34061_13_f&fid=34061&url=http%3A%2F%2Fwww.biomedcentral.com%2Fcurropininvestigdrugs%2F No description available (Source: Current Opinion in Investigational Drugs) Current Opinion in Investigational Drugs journals http://www.medworm.com/rss/comments.php?id=4110283 Sun, 24 Oct 2010 23:00:00 +0100 4110283 The growth receptors and their role in wound healing http://www.medworm.com/index.php?rid=4110282&cid=s_34061_13_f&fid=34061&url=http%3A%2F%2Fwww.biomedcentral.com%2Fcurropininvestigdrugs%2F No description available (Source: Current Opinion in Investigational Drugs) Current Opinion in Investigational Drugs journals http://www.medworm.com/rss/comments.php?id=4110282 Sun, 24 Oct 2010 23:00:00 +0100 4110282 Targeting Th2 cytokines in fibrotic diseases http://www.medworm.com/index.php?rid=4110281&cid=s_34061_13_f&fid=34061&url=http%3A%2F%2Fwww.biomedcentral.com%2Fcurropininvestigdrugs%2F No description available (Source: Current Opinion in Investigational Drugs) Current Opinion in Investigational Drugs journals http://www.medworm.com/rss/comments.php?id=4110281 Sun, 24 Oct 2010 23:00:00 +0100 4110281 Muscarinic receptors as targets for anti-inflammatory therapy http://www.medworm.com/index.php?rid=4110280&cid=s_34061_13_f&fid=34061&url=http%3A%2F%2Fwww.biomedcentral.com%2Fcurropininvestigdrugs%2F No description available (Source: Current Opinion in Investigational Drugs) Current Opinion in Investigational Drugs journals http://www.medworm.com/rss/comments.php?id=4110280 Sun, 24 Oct 2010 23:00:00 +0100 4110280 Function of NOD-like receptors in immunity and disease http://www.medworm.com/index.php?rid=4110279&cid=s_34061_13_f&fid=34061&url=http%3A%2F%2Fwww.biomedcentral.com%2Fcurropininvestigdrugs%2F No description available (Source: Current Opinion in Investigational Drugs) Current Opinion in Investigational Drugs journals http://www.medworm.com/rss/comments.php?id=4110279 Sun, 24 Oct 2010 23:00:00 +0100 4110279 Novel treatments for systemic lupus erythematosus http://www.medworm.com/index.php?rid=4110278&cid=s_34061_13_f&fid=34061&url=http%3A%2F%2Fwww.biomedcentral.com%2Fcurropininvestigdrugs%2F No description available (Source: Current Opinion in Investigational Drugs) Current Opinion in Investigational Drugs journals http://www.medworm.com/rss/comments.php?id=4110278 Sun, 24 Oct 2010 23:00:00 +0100 4110278 Resetting autoimmunity in the nervous system: The role of hematopoietic stem cell transplantation http://www.medworm.com/index.php?rid=4110277&cid=s_34061_13_f&fid=34061&url=http%3A%2F%2Fwww.biomedcentral.com%2Fcurropininvestigdrugs%2F No description available (Source: Current Opinion in Investigational Drugs) Current Opinion in Investigational Drugs journals http://www.medworm.com/rss/comments.php?id=4110277 Sun, 24 Oct 2010 23:00:00 +0100 4110277 Teriflunomide, an inhibitor of dihydroorotate dehydrogenase for the potential oral treatment of multiple sclerosis http://www.medworm.com/index.php?rid=4110276&cid=s_34061_13_f&fid=34061&url=http%3A%2F%2Fwww.biomedcentral.com%2Fcurropininvestigdrugs%2F No description available (Source: Current Opinion in Investigational Drugs) Current Opinion in Investigational Drugs journals http://www.medworm.com/rss/comments.php?id=4110276 Sun, 24 Oct 2010 23:00:00 +0100 4110276 Mutations in the melanocortin-3 receptor (MC3R) gene: Impact on human obesity or adiposity http://www.medworm.com/index.php?rid=4005438&cid=s_34061_13_f&fid=34061&url=http%3A%2F%2Fwww.biomedcentral.com%2Fcurropininvestigdrugs%2F No description available (Source: Current Opinion in Investigational Drugs) Current Opinion in Investigational Drugs journals http://www.medworm.com/rss/comments.php?id=4005438 Tue, 21 Sep 2010 23:00:00 +0100 4005438 Appetite- and volume-regulating neuropeptides: Role in treating alcohol dependence http://www.medworm.com/index.php?rid=4005437&cid=s_34061_13_f&fid=34061&url=http%3A%2F%2Fwww.biomedcentral.com%2Fcurropininvestigdrugs%2F No description available (Source: Current Opinion in Investigational Drugs) Current Opinion in Investigational Drugs journals http://www.medworm.com/rss/comments.php?id=4005437 Tue, 21 Sep 2010 23:00:00 +0100 4005437 Plant-derived therapeutics for the treatment of metabolic syndrome http://www.medworm.com/index.php?rid=4005436&cid=s_34061_13_f&fid=34061&url=http%3A%2F%2Fwww.biomedcentral.com%2Fcurropininvestigdrugs%2F No description available (Source: Current Opinion in Investigational Drugs) Current Opinion in Investigational Drugs journals http://www.medworm.com/rss/comments.php?id=4005436 Tue, 21 Sep 2010 23:00:00 +0100 4005436 Testosterone therapy in women with androgen deficiency: Its time has come http://www.medworm.com/index.php?rid=4005435&cid=s_34061_13_f&fid=34061&url=http%3A%2F%2Fwww.biomedcentral.com%2Fcurropininvestigdrugs%2F No description available (Source: Current Opinion in Investigational Drugs) Current Opinion in Investigational Drugs journals http://www.medworm.com/rss/comments.php?id=4005435 Tue, 21 Sep 2010 23:00:00 +0100 4005435 Thyroid hormone receptor and lipid regulation http://www.medworm.com/index.php?rid=4005434&cid=s_34061_13_f&fid=34061&url=http%3A%2F%2Fwww.biomedcentral.com%2Fcurropininvestigdrugs%2F No description available (Source: Current Opinion in Investigational Drugs) Current Opinion in Investigational Drugs journals http://www.medworm.com/rss/comments.php?id=4005434 Tue, 21 Sep 2010 23:00:00 +0100 4005434 Growth hormone-releasing factor agonists for the treatment of HIV-associated lipodystrophy http://www.medworm.com/index.php?rid=4005433&cid=s_34061_13_f&fid=34061&url=http%3A%2F%2Fwww.biomedcentral.com%2Fcurropininvestigdrugs%2F No description available (Source: Current Opinion in Investigational Drugs) Current Opinion in Investigational Drugs journals http://www.medworm.com/rss/comments.php?id=4005433 Tue, 21 Sep 2010 23:00:00 +0100 4005433 The mechanism of action for oxyntomodulin in the regulation of obesity http://www.medworm.com/index.php?rid=4005432&cid=s_34061_13_f&fid=34061&url=http%3A%2F%2Fwww.biomedcentral.com%2Fcurropininvestigdrugs%2F No description available (Source: Current Opinion in Investigational Drugs) Current Opinion in Investigational Drugs journals http://www.medworm.com/rss/comments.php?id=4005432 Tue, 21 Sep 2010 23:00:00 +0100 4005432 BI-10773, a sodium-glucose cotransporter 2 inhibitor for the potential oral treatment of type 2 diabetes mellitus http://www.medworm.com/index.php?rid=4005431&cid=s_34061_13_f&fid=34061&url=http%3A%2F%2Fwww.biomedcentral.com%2Fcurropininvestigdrugs%2F No description available (Source: Current Opinion in Investigational Drugs) Current Opinion in Investigational Drugs journals http://www.medworm.com/rss/comments.php?id=4005431 Tue, 21 Sep 2010 23:00:00 +0100 4005431 Comparative effectiveness studies of medications http://www.medworm.com/index.php?rid=3922231&cid=s_34061_13_f&fid=34061&url=http%3A%2F%2Fwww.biomedcentral.com%2Fcurropininvestigdrugs%2F No description available (Source: Current Opinion in Investigational Drugs) Current Opinion in Investigational Drugs journals http://www.medworm.com/rss/comments.php?id=3922231 Wed, 18 Aug 2010 23:00:00 +0100 3922231 Apolipoprotein A-I and its mimetics for the treatment of atherosclerosis http://www.medworm.com/index.php?rid=3922230&cid=s_34061_13_f&fid=34061&url=http%3A%2F%2Fwww.biomedcentral.com%2Fcurropininvestigdrugs%2F No description available (Source: Current Opinion in Investigational Drugs) Current Opinion in Investigational Drugs journals http://www.medworm.com/rss/comments.php?id=3922230 Wed, 18 Aug 2010 23:00:00 +0100 3922230 Targeting hyaluronan of the endothelial glycocalyx for therapeutic intervention http://www.medworm.com/index.php?rid=3922229&cid=s_34061_13_f&fid=34061&url=http%3A%2F%2Fwww.biomedcentral.com%2Fcurropininvestigdrugs%2F No description available (Source: Current Opinion in Investigational Drugs) Current Opinion in Investigational Drugs journals http://www.medworm.com/rss/comments.php?id=3922229 Wed, 18 Aug 2010 23:00:00 +0100 3922229 Primate models for cardiovascular drug research and development http://www.medworm.com/index.php?rid=3922228&cid=s_34061_13_f&fid=34061&url=http%3A%2F%2Fwww.biomedcentral.com%2Fcurropininvestigdrugs%2F No description available (Source: Current Opinion in Investigational Drugs) Current Opinion in Investigational Drugs journals http://www.medworm.com/rss/comments.php?id=3922228 Wed, 18 Aug 2010 23:00:00 +0100 3922228 Chronic kidney disease-associated anemia: New remedies http://www.medworm.com/index.php?rid=3922227&cid=s_34061_13_f&fid=34061&url=http%3A%2F%2Fwww.biomedcentral.com%2Fcurropininvestigdrugs%2F No description available (Source: Current Opinion in Investigational Drugs) Current Opinion in Investigational Drugs journals http://www.medworm.com/rss/comments.php?id=3922227 Wed, 18 Aug 2010 23:00:00 +0100 3922227 Cinaciguat, a soluble guanylate cyclase activator for the potential treatment of acute heart failure http://www.medworm.com/index.php?rid=3922226&cid=s_34061_13_f&fid=34061&url=http%3A%2F%2Fwww.biomedcentral.com%2Fcurropininvestigdrugs%2F No description available (Source: Current Opinion in Investigational Drugs) Current Opinion in Investigational Drugs journals http://www.medworm.com/rss/comments.php?id=3922226 Wed, 18 Aug 2010 23:00:00 +0100 3922226 M-118, a novel, low-molecular-weight heparin for the potential treatment of cardiovascular disorders http://www.medworm.com/index.php?rid=3922225&cid=s_34061_13_f&fid=34061&url=http%3A%2F%2Fwww.biomedcentral.com%2Fcurropininvestigdrugs%2F No description available (Source: Current Opinion in Investigational Drugs) Current Opinion in Investigational Drugs journals http://www.medworm.com/rss/comments.php?id=3922225 Wed, 18 Aug 2010 23:00:00 +0100 3922225 Macitentan, a tissue-targeting endothelin receptor antagonist for the potential oral treatment of pulmonary arterial hypertension and idiopathic pulmonary fibrosis http://www.medworm.com/index.php?rid=3922224&cid=s_34061_13_f&fid=34061&url=http%3A%2F%2Fwww.biomedcentral.com%2Fcurropininvestigdrugs%2F No description available (Source: Current Opinion in Investigational Drugs) Current Opinion in Investigational Drugs journals http://www.medworm.com/rss/comments.php?id=3922224 Wed, 18 Aug 2010 23:00:00 +0100 3922224 Antiretroviral drug development for HIV: Challenges for the future http://www.medworm.com/index.php?rid=3856205&cid=s_34061_13_f&fid=34061&url=http%3A%2F%2Fwww.biomedcentral.com%2Fcurropininvestigdrugs%2F No description available (Source: Current Opinion in Investigational Drugs) Current Opinion in Investigational Drugs journals http://www.medworm.com/rss/comments.php?id=3856205 Tue, 20 Jul 2010 23:00:00 +0100 3856205 Antimicrobial peptides for leishmaniasis http://www.medworm.com/index.php?rid=3856204&cid=s_34061_13_f&fid=34061&url=http%3A%2F%2Fwww.biomedcentral.com%2Fcurropininvestigdrugs%2F No description available (Source: Current Opinion in Investigational Drugs) Current Opinion in Investigational Drugs journals http://www.medworm.com/rss/comments.php?id=3856204 Tue, 20 Jul 2010 23:00:00 +0100 3856204 Diamidines for human African trypanosomiasis http://www.medworm.com/index.php?rid=3856203&cid=s_34061_13_f&fid=34061&url=http%3A%2F%2Fwww.biomedcentral.com%2Fcurropininvestigdrugs%2F No description available (Source: Current Opinion in Investigational Drugs) Current Opinion in Investigational Drugs journals http://www.medworm.com/rss/comments.php?id=3856203 Tue, 20 Jul 2010 23:00:00 +0100 3856203 Optimal antiretroviral therapy: HIV-1 treatment strategies to avoid and overcome drug resistance http://www.medworm.com/index.php?rid=3856202&cid=s_34061_13_f&fid=34061&url=http%3A%2F%2Fwww.biomedcentral.com%2Fcurropininvestigdrugs%2F No description available (Source: Current Opinion in Investigational Drugs) Current Opinion in Investigational Drugs journals http://www.medworm.com/rss/comments.php?id=3856202 Tue, 20 Jul 2010 23:00:00 +0100 3856202 Cyclophilin inhibitors for the treatment of HCV infection http://www.medworm.com/index.php?rid=3856201&cid=s_34061_13_f&fid=34061&url=http%3A%2F%2Fwww.biomedcentral.com%2Fcurropininvestigdrugs%2F No description available (Source: Current Opinion in Investigational Drugs) Current Opinion in Investigational Drugs journals http://www.medworm.com/rss/comments.php?id=3856201 Tue, 20 Jul 2010 23:00:00 +0100 3856201 Cholera toxin B subunit modulation of mucosal vaccines for infectious and autoimmune diseases http://www.medworm.com/index.php?rid=3856200&cid=s_34061_13_f&fid=34061&url=http%3A%2F%2Fwww.biomedcentral.com%2Fcurropininvestigdrugs%2F No description available (Source: Current Opinion in Investigational Drugs) Current Opinion in Investigational Drugs journals http://www.medworm.com/rss/comments.php?id=3856200 Tue, 20 Jul 2010 23:00:00 +0100 3856200 Outpatient parenteral antimicrobial therapy: Recent developments and future prospects http://www.medworm.com/index.php?rid=3856199&cid=s_34061_13_f&fid=34061&url=http%3A%2F%2Fwww.biomedcentral.com%2Fcurropininvestigdrugs%2F No description available (Source: Current Opinion in Investigational Drugs) Current Opinion in Investigational Drugs journals http://www.medworm.com/rss/comments.php?id=3856199 Tue, 20 Jul 2010 23:00:00 +0100 3856199 Cenicriviroc, an orally active CCR5 antagonist for the potential treatment of HIV infection http://www.medworm.com/index.php?rid=3856198&cid=s_34061_13_f&fid=34061&url=http%3A%2F%2Fwww.biomedcentral.com%2Fcurropininvestigdrugs%2F No description available (Source: Current Opinion in Investigational Drugs) Current Opinion in Investigational Drugs journals http://www.medworm.com/rss/comments.php?id=3856198 Tue, 20 Jul 2010 23:00:00 +0100 3856198 Danoprevir, a small-molecule NS3/4A protease inhibitor for the potential oral treatment of HCV infection http://www.medworm.com/index.php?rid=3856197&cid=s_34061_13_f&fid=34061&url=http%3A%2F%2Fwww.biomedcentral.com%2Fcurropininvestigdrugs%2F No description available (Source: Current Opinion in Investigational Drugs) Current Opinion in Investigational Drugs journals http://www.medworm.com/rss/comments.php?id=3856197 Tue, 20 Jul 2010 23:00:00 +0100 3856197 Vacc-4x, a therapeutic vaccine comprised of four engineered peptides for the potential treatment of HIV infection http://www.medworm.com/index.php?rid=3856196&cid=s_34061_13_f&fid=34061&url=http%3A%2F%2Fwww.biomedcentral.com%2Fcurropininvestigdrugs%2F No description available (Source: Current Opinion in Investigational Drugs) Current Opinion in Investigational Drugs journals http://www.medworm.com/rss/comments.php?id=3856196 Tue, 20 Jul 2010 23:00:00 +0100 3856196 Placebo effects in treating migraine and other headaches http://www.medworm.com/index.php?rid=3755538&cid=s_34061_13_f&fid=34061&url=http%3A%2F%2Fwww.biomedcentral.com%2Fcurropininvestigdrugs%2F No description available (Source: Current Opinion in Investigational Drugs) Current Opinion in Investigational Drugs journals http://www.medworm.com/rss/comments.php?id=3755538 Mon, 21 Jun 2010 23:00:00 +0100 3755538 Cognitive effects of muscarinic M1 functional agonists in non-human primates and clinical trials http://www.medworm.com/index.php?rid=3755537&cid=s_34061_13_f&fid=34061&url=http%3A%2F%2Fwww.biomedcentral.com%2Fcurropininvestigdrugs%2F No description available (Source: Current Opinion in Investigational Drugs) Current Opinion in Investigational Drugs journals http://www.medworm.com/rss/comments.php?id=3755537 Mon, 21 Jun 2010 23:00:00 +0100 3755537 The alpha2-delta protein: An auxiliary subunit of voltage-dependent calcium channels as a recognized drug target http://www.medworm.com/index.php?rid=3755536&cid=s_34061_13_f&fid=34061&url=http%3A%2F%2Fwww.biomedcentral.com%2Fcurropininvestigdrugs%2F No description available (Source: Current Opinion in Investigational Drugs) Current Opinion in Investigational Drugs journals http://www.medworm.com/rss/comments.php?id=3755536 Mon, 21 Jun 2010 23:00:00 +0100 3755536 Using NMR approaches to drive the search for new CNS therapeutics http://www.medworm.com/index.php?rid=3755535&cid=s_34061_13_f&fid=34061&url=http%3A%2F%2Fwww.biomedcentral.com%2Fcurropininvestigdrugs%2F No description available (Source: Current Opinion in Investigational Drugs) Current Opinion in Investigational Drugs journals http://www.medworm.com/rss/comments.php?id=3755535 Mon, 21 Jun 2010 23:00:00 +0100 3755535 Neuroinflammation and the prospects for anti-inflammatory treatment of Parkinson's disease http://www.medworm.com/index.php?rid=3755534&cid=s_34061_13_f&fid=34061&url=http%3A%2F%2Fwww.biomedcentral.com%2Fcurropininvestigdrugs%2F No description available (Source: Current Opinion in Investigational Drugs) Current Opinion in Investigational Drugs journals http://www.medworm.com/rss/comments.php?id=3755534 Mon, 21 Jun 2010 23:00:00 +0100 3755534 The use of mechanistic biomarkers for evaluating investigational CNS compounds in early drug development http://www.medworm.com/index.php?rid=3755533&cid=s_34061_13_f&fid=34061&url=http%3A%2F%2Fwww.biomedcentral.com%2Fcurropininvestigdrugs%2F No description available (Source: Current Opinion in Investigational Drugs) Current Opinion in Investigational Drugs journals http://www.medworm.com/rss/comments.php?id=3755533 Mon, 21 Jun 2010 23:00:00 +0100 3755533 The importance of 5-HT1A receptor agonism in antipsychotic drug action: Rationale and perspectives http://www.medworm.com/index.php?rid=3755532&cid=s_34061_13_f&fid=34061&url=http%3A%2F%2Fwww.biomedcentral.com%2Fcurropininvestigdrugs%2F No description available (Source: Current Opinion in Investigational Drugs) Current Opinion in Investigational Drugs journals http://www.medworm.com/rss/comments.php?id=3755532 Mon, 21 Jun 2010 23:00:00 +0100 3755532 LY-2140023, a prodrug of the group II metabotropic glutamate receptor agonist LY-404039 for the potential treatment of schizophrenia http://www.medworm.com/index.php?rid=3755531&cid=s_34061_13_f&fid=34061&url=http%3A%2F%2Fwww.biomedcentral.com%2Fcurropininvestigdrugs%2F No description available (Source: Current Opinion in Investigational Drugs) Current Opinion in Investigational Drugs journals http://www.medworm.com/rss/comments.php?id=3755531 Mon, 21 Jun 2010 23:00:00 +0100 3755531 The use of dyslipidemic hamsters to evaluate drug-induced alterations in reverse cholesterol transport http://www.medworm.com/index.php?rid=3289235&cid=s_34061_13_f&fid=34061&url=http%3A%2F%2Fwww.biomedcentral.com%2Fcurropininvestigdrugs%2F No description available (Source: Current Opinion in Investigational Drugs) Current Opinion in Investigational Drugs journals http://www.medworm.com/rss/comments.php?id=3289235 Thu, 18 Feb 2010 00:00:00 +0100 3289235 Angiogenesis, neurogenesis and brain recovery of function following injury http://www.medworm.com/index.php?rid=3289234&cid=s_34061_13_f&fid=34061&url=http%3A%2F%2Fwww.biomedcentral.com%2Fcurropininvestigdrugs%2F No description available (Source: Current Opinion in Investigational Drugs) Current Opinion in Investigational Drugs journals http://www.medworm.com/rss/comments.php?id=3289234 Thu, 18 Feb 2010 00:00:00 +0100 3289234 Vitamin D deficiency and cardiovascular disease: Is there a role for vitamin D therapy in heart failure? http://www.medworm.com/index.php?rid=3289233&cid=s_34061_13_f&fid=34061&url=http%3A%2F%2Fwww.biomedcentral.com%2Fcurropininvestigdrugs%2F No description available (Source: Current Opinion in Investigational Drugs) Current Opinion in Investigational Drugs journals http://www.medworm.com/rss/comments.php?id=3289233 Thu, 18 Feb 2010 00:00:00 +0100 3289233 Antagonists of bone morphogenetic proteins in kidney disease http://www.medworm.com/index.php?rid=3289232&cid=s_34061_13_f&fid=34061&url=http%3A%2F%2Fwww.biomedcentral.com%2Fcurropininvestigdrugs%2F No description available (Source: Current Opinion in Investigational Drugs) Current Opinion in Investigational Drugs journals http://www.medworm.com/rss/comments.php?id=3289232 Thu, 18 Feb 2010 00:00:00 +0100 3289232 Drug interactions with HMG-CoA reductase inhibitors (statins): The importance of CYP enzymes, transporters and pharmacogenetic http://www.medworm.com/index.php?rid=3289231&cid=s_34061_13_f&fid=34061&url=http%3A%2F%2Fwww.biomedcentral.com%2Fcurropininvestigdrugs%2F No description available (Source: Current Opinion in Investigational Drugs) Current Opinion in Investigational Drugs journals http://www.medworm.com/rss/comments.php?id=3289231 Thu, 18 Feb 2010 00:00:00 +0100 3289231 YM-150, a Factor Xa inhibitor for the prevention of venous thromboembolism and coronary artery disease http://www.medworm.com/index.php?rid=3289230&cid=s_34061_13_f&fid=34061&url=http%3A%2F%2Fwww.biomedcentral.com%2Fcurropininvestigdrugs%2F No description available (Source: Current Opinion in Investigational Drugs) Current Opinion in Investigational Drugs journals http://www.medworm.com/rss/comments.php?id=3289230 Thu, 18 Feb 2010 00:00:00 +0100 3289230 Elinogrel, a reversible P2Y12 receptor antagonist for the treatment of acute coronary syndrome and prevention of secondary thrombotic events http://www.medworm.com/index.php?rid=3289229&cid=s_34061_13_f&fid=34061&url=http%3A%2F%2Fwww.biomedcentral.com%2Fcurropininvestigdrugs%2F No description available (Source: Current Opinion in Investigational Drugs) Current Opinion in Investigational Drugs journals http://www.medworm.com/rss/comments.php?id=3289229 Thu, 18 Feb 2010 00:00:00 +0100 3289229 CD-NP, a chimeric natriuretic peptide for the treatment of heart failure http://www.medworm.com/index.php?rid=3289228&cid=s_34061_13_f&fid=34061&url=http%3A%2F%2Fwww.biomedcentral.com%2Fcurropininvestigdrugs%2F No description available (Source: Current Opinion in Investigational Drugs) Current Opinion in Investigational Drugs journals http://www.medworm.com/rss/comments.php?id=3289228 Thu, 18 Feb 2010 00:00:00 +0100 3289228 RVX-208, a stimulator of apolipoprotein AI gene expression for the treatment of cardiovascular diseases http://www.medworm.com/index.php?rid=3289227&cid=s_34061_13_f&fid=34061&url=http%3A%2F%2Fwww.biomedcentral.com%2Fcurropininvestigdrugs%2F No description available (Source: Current Opinion in Investigational Drugs) Current Opinion in Investigational Drugs journals http://www.medworm.com/rss/comments.php?id=3289227 Thu, 18 Feb 2010 00:00:00 +0100 3289227 Lipid II and other bactoprenol-bound cell wall precursors as drug targets http://www.medworm.com/index.php?rid=3228930&cid=s_34061_13_f&fid=34061&url=http%3A%2F%2Fwww.biomedcentral.com%2Fcurropininvestigdrugs%2F No description available (Source: Current Opinion in Investigational Drugs) Current Opinion in Investigational Drugs journals http://www.medworm.com/rss/comments.php?id=3228930 Tue, 26 Jan 2010 00:00:00 +0100 3228930 Building an insurance against modern pandemics http://www.medworm.com/index.php?rid=3225770&cid=s_34061_13_f&fid=34061&url=http%3A%2F%2Fwww.biomedcentral.com%2Fcurropininvestigdrugs%2F No description available (Source: Current Opinion in Investigational Drugs) Current Opinion in Investigational Drugs journals http://www.medworm.com/rss/comments.php?id=3225770 Tue, 26 Jan 2010 00:00:00 +0100 3225770 Genomics and systems biology in malaria drug discovery http://www.medworm.com/index.php?rid=3225769&cid=s_34061_13_f&fid=34061&url=http%3A%2F%2Fwww.biomedcentral.com%2Fcurropininvestigdrugs%2F No description available (Source: Current Opinion in Investigational Drugs) Current Opinion in Investigational Drugs journals http://www.medworm.com/rss/comments.php?id=3225769 Tue, 26 Jan 2010 00:00:00 +0100 3225769 West Nile Virus: Is a vaccine needed? http://www.medworm.com/index.php?rid=3225768&cid=s_34061_13_f&fid=34061&url=http%3A%2F%2Fwww.biomedcentral.com%2Fcurropininvestigdrugs%2F No description available (Source: Current Opinion in Investigational Drugs) Current Opinion in Investigational Drugs journals http://www.medworm.com/rss/comments.php?id=3225768 Tue, 26 Jan 2010 00:00:00 +0100 3225768 Apicomplexa, trypanosoma and parasitic nematode protein kinases as antiparasitic therapeutic targets http://www.medworm.com/index.php?rid=3225767&cid=s_34061_13_f&fid=34061&url=http%3A%2F%2Fwww.biomedcentral.com%2Fcurropininvestigdrugs%2F No description available (Source: Current Opinion in Investigational Drugs) Current Opinion in Investigational Drugs journals http://www.medworm.com/rss/comments.php?id=3225767 Tue, 26 Jan 2010 00:00:00 +0100 3225767 Novel triazole antifungal drugs: Focus on isavuconazole, ravuconazole and albaconazole http://www.medworm.com/index.php?rid=3225766&cid=s_34061_13_f&fid=34061&url=http%3A%2F%2Fwww.biomedcentral.com%2Fcurropininvestigdrugs%2F No description available (Source: Current Opinion in Investigational Drugs) Current Opinion in Investigational Drugs journals http://www.medworm.com/rss/comments.php?id=3225766 Tue, 26 Jan 2010 00:00:00 +0100 3225766 Inhibition of HCV p7 as a therapeutic target http://www.medworm.com/index.php?rid=3225765&cid=s_34061_13_f&fid=34061&url=http%3A%2F%2Fwww.biomedcentral.com%2Fcurropininvestigdrugs%2F No description available (Source: Current Opinion in Investigational Drugs) Current Opinion in Investigational Drugs journals http://www.medworm.com/rss/comments.php?id=3225765 Tue, 26 Jan 2010 00:00:00 +0100 3225765 The pleuromutilin antibiotics: A new class for human use http://www.medworm.com/index.php?rid=3225764&cid=s_34061_13_f&fid=34061&url=http%3A%2F%2Fwww.biomedcentral.com%2Fcurropininvestigdrugs%2F No description available (Source: Current Opinion in Investigational Drugs) Current Opinion in Investigational Drugs journals http://www.medworm.com/rss/comments.php?id=3225764 Tue, 26 Jan 2010 00:00:00 +0100 3225764 IDX-899, an aryl phosphinate-indole non-nucleoside reverse transcriptase inhibitor for the potential treatment of HIV infection http://www.medworm.com/index.php?rid=3225763&cid=s_34061_13_f&fid=34061&url=http%3A%2F%2Fwww.biomedcentral.com%2Fcurropininvestigdrugs%2F No description available (Source: Current Opinion in Investigational Drugs) Current Opinion in Investigational Drugs journals http://www.medworm.com/rss/comments.php?id=3225763 Tue, 26 Jan 2010 00:00:00 +0100 3225763 Drugs to treat fibromyalgia - The transatlantic difference http://www.medworm.com/index.php?rid=3116624&cid=s_34061_13_f&fid=34061&url=http%3A%2F%2Fwww.biomedcentral.com%2Fcurropininvestigdrugs%2F No description available (Source: Current Opinion in Investigational Drugs) Current Opinion in Investigational Drugs journals http://www.medworm.com/rss/comments.php?id=3116624 Mon, 21 Dec 2009 00:00:00 +0100 3116624 The tetrahydrobiopterin pathway and pain http://www.medworm.com/index.php?rid=3116623&cid=s_34061_13_f&fid=34061&url=http%3A%2F%2Fwww.biomedcentral.com%2Fcurropininvestigdrugs%2F No description available (Source: Current Opinion in Investigational Drugs) Current Opinion in Investigational Drugs journals http://www.medworm.com/rss/comments.php?id=3116623 Mon, 21 Dec 2009 00:00:00 +0100 3116623 COX-2 inhibitors as antidepressants and antipsychotics: Clinical evidence http://www.medworm.com/index.php?rid=3116622&cid=s_34061_13_f&fid=34061&url=http%3A%2F%2Fwww.biomedcentral.com%2Fcurropininvestigdrugs%2F No description available (Source: Current Opinion in Investigational Drugs) Current Opinion in Investigational Drugs journals http://www.medworm.com/rss/comments.php?id=3116622 Mon, 21 Dec 2009 00:00:00 +0100 3116622 FAAH and MAGL inhibitors: Therapeutic opportunities from regulating endocannabinoid levels http://www.medworm.com/index.php?rid=3116621&cid=s_34061_13_f&fid=34061&url=http%3A%2F%2Fwww.biomedcentral.com%2Fcurropininvestigdrugs%2F No description available (Source: Current Opinion in Investigational Drugs) Current Opinion in Investigational Drugs journals http://www.medworm.com/rss/comments.php?id=3116621 Mon, 21 Dec 2009 00:00:00 +0100 3116621 Neurobiological mechanisms of addiction: Focus on corticotropin-releasing factor http://www.medworm.com/index.php?rid=3116620&cid=s_34061_13_f&fid=34061&url=http%3A%2F%2Fwww.biomedcentral.com%2Fcurropininvestigdrugs%2F No description available (Source: Current Opinion in Investigational Drugs) Current Opinion in Investigational Drugs journals http://www.medworm.com/rss/comments.php?id=3116620 Mon, 21 Dec 2009 00:00:00 +0100 3116620 Neurophysiological methodologies: Diagnosis of peripheral nerve disease and assessment of pharmacological agents http://www.medworm.com/index.php?rid=3116619&cid=s_34061_13_f&fid=34061&url=http%3A%2F%2Fwww.biomedcentral.com%2Fcurropininvestigdrugs%2F No description available (Source: Current Opinion in Investigational Drugs) Current Opinion in Investigational Drugs journals http://www.medworm.com/rss/comments.php?id=3116619 Mon, 21 Dec 2009 00:00:00 +0100 3116619 BL-1020, an oral antipsychotic agent that reduces dopamine activity and enhances GABAA activity, for the treatment of schizophrenia http://www.medworm.com/index.php?rid=3116618&cid=s_34061_13_f&fid=34061&url=http%3A%2F%2Fwww.biomedcentral.com%2Fcurropininvestigdrugs%2F No description available (Source: Current Opinion in Investigational Drugs) Current Opinion in Investigational Drugs journals http://www.medworm.com/rss/comments.php?id=3116618 Mon, 21 Dec 2009 00:00:00 +0100 3116618 Almorexant, a dual orexin receptor antagonist for the treatment of insomnia http://www.medworm.com/index.php?rid=3116617&cid=s_34061_13_f&fid=34061&url=http%3A%2F%2Fwww.biomedcentral.com%2Fcurropininvestigdrugs%2F No description available (Source: Current Opinion in Investigational Drugs) Current Opinion in Investigational Drugs journals http://www.medworm.com/rss/comments.php?id=3116617 Mon, 21 Dec 2009 00:00:00 +0100 3116617 Kinase inhibitor selectivity http://www.medworm.com/index.php?rid=3041191&cid=s_34061_13_f&fid=34061&url=http%3A%2F%2Fwww.biomedcentral.com%2Fcurropininvestigdrugs%2F No description available (Source: Current Opinion in Investigational Drugs) Current Opinion in Investigational Drugs journals http://www.medworm.com/rss/comments.php?id=3041191 Fri, 20 Nov 2009 00:00:00 +0100 3041191 Autophagy inhibition in combination cancer treatment http://www.medworm.com/index.php?rid=3041190&cid=s_34061_13_f&fid=34061&url=http%3A%2F%2Fwww.biomedcentral.com%2Fcurropininvestigdrugs%2F No description available (Source: Current Opinion in Investigational Drugs) Current Opinion in Investigational Drugs journals http://www.medworm.com/rss/comments.php?id=3041190 Fri, 20 Nov 2009 00:00:00 +0100 3041190 Microbial antitumor drugs: Natural products of microbial origin as anticancer agents http://www.medworm.com/index.php?rid=3041189&cid=s_34061_13_f&fid=34061&url=http%3A%2F%2Fwww.biomedcentral.com%2Fcurropininvestigdrugs%2F No description available (Source: Current Opinion in Investigational Drugs) Current Opinion in Investigational Drugs journals http://www.medworm.com/rss/comments.php?id=3041189 Fri, 20 Nov 2009 00:00:00 +0100 3041189 Phosphatases as targets for cancer treatment http://www.medworm.com/index.php?rid=3041188&cid=s_34061_13_f&fid=34061&url=http%3A%2F%2Fwww.biomedcentral.com%2Fcurropininvestigdrugs%2F No description available (Source: Current Opinion in Investigational Drugs) Current Opinion in Investigational Drugs journals http://www.medworm.com/rss/comments.php?id=3041188 Fri, 20 Nov 2009 00:00:00 +0100 3041188 The role of KRAS mutations in resistance to EGFR inhibition in the treatment of cancer http://www.medworm.com/index.php?rid=3041187&cid=s_34061_13_f&fid=34061&url=http%3A%2F%2Fwww.biomedcentral.com%2Fcurropininvestigdrugs%2F No description available (Source: Current Opinion in Investigational Drugs) Current Opinion in Investigational Drugs journals http://www.medworm.com/rss/comments.php?id=3041187 Fri, 20 Nov 2009 00:00:00 +0100 3041187 GM-CSF-secreting vaccines for solid tumors http://www.medworm.com/index.php?rid=3041186&cid=s_34061_13_f&fid=34061&url=http%3A%2F%2Fwww.biomedcentral.com%2Fcurropininvestigdrugs%2F No description available (Source: Current Opinion in Investigational Drugs) Current Opinion in Investigational Drugs journals http://www.medworm.com/rss/comments.php?id=3041186 Fri, 20 Nov 2009 00:00:00 +0100 3041186 Combination chemotherapy for head and neck cancer: The addition of Bcl-2 inhibitors http://www.medworm.com/index.php?rid=3041185&cid=s_34061_13_f&fid=34061&url=http%3A%2F%2Fwww.biomedcentral.com%2Fcurropininvestigdrugs%2F No description available (Source: Current Opinion in Investigational Drugs) Current Opinion in Investigational Drugs journals http://www.medworm.com/rss/comments.php?id=3041185 Fri, 20 Nov 2009 00:00:00 +0100 3041185 Antiangiogenic therapies in breast cancer http://www.medworm.com/index.php?rid=3041184&cid=s_34061_13_f&fid=34061&url=http%3A%2F%2Fwww.biomedcentral.com%2Fcurropininvestigdrugs%2F No description available (Source: Current Opinion in Investigational Drugs) Current Opinion in Investigational Drugs journals http://www.medworm.com/rss/comments.php?id=3041184 Fri, 20 Nov 2009 00:00:00 +0100 3041184 Subject Index - Volume 10 http://www.medworm.com/index.php?rid=3041183&cid=s_34061_13_f&fid=34061&url=http%3A%2F%2Fwww.biomedcentral.com%2Fcurropininvestigdrugs%2F No description available (Source: Current Opinion in Investigational Drugs) Current Opinion in Investigational Drugs journals http://www.medworm.com/rss/comments.php?id=3041183 Fri, 20 Nov 2009 00:00:00 +0100 3041183 PI3K isoforms as drug targets in inflammatory diseases: Lessons from pharmacological and genetic strategies http://www.medworm.com/index.php?rid=2956220&cid=s_34061_13_f&fid=34061&url=http%3A%2F%2Fwww.biomedcentral.com%2Fcurropininvestigdrugs%2F No description available (Source: Current Opinion in Investigational Drugs) Current Opinion in Investigational Drugs journals http://www.medworm.com/rss/comments.php?id=2956220 Tue, 27 Oct 2009 00:00:00 +0100 2956220 The role of sphingosine-1-phosphate receptor modulators in the prevention of transplant rejection and autoimmune diseases http://www.medworm.com/index.php?rid=2956219&cid=s_34061_13_f&fid=34061&url=http%3A%2F%2Fwww.biomedcentral.com%2Fcurropininvestigdrugs%2F No description available (Source: Current Opinion in Investigational Drugs) Current Opinion in Investigational Drugs journals http://www.medworm.com/rss/comments.php?id=2956219 Tue, 27 Oct 2009 00:00:00 +0100 2956219 Paper alert http://www.medworm.com/index.php?rid=2941013&cid=s_34061_13_f&fid=34061&url=http%3A%2F%2Fwww.biomedcentral.com%2Fcurropininvestigdrugs%2F No description available (Source: Current Opinion in Investigational Drugs) Current Opinion in Investigational Drugs journals http://www.medworm.com/rss/comments.php?id=2941013 Tue, 27 Oct 2009 00:00:00 +0100 2941013 Patent alert http://www.medworm.com/index.php?rid=2941012&cid=s_34061_13_f&fid=34061&url=http%3A%2F%2Fwww.biomedcentral.com%2Fcurropininvestigdrugs%2F No description available (Source: Current Opinion in Investigational Drugs) Current Opinion in Investigational Drugs journals http://www.medworm.com/rss/comments.php?id=2941012 Tue, 27 Oct 2009 00:00:00 +0100 2941012 Editorial Overview - Something old, something new - Colchicine in the 21st century http://www.medworm.com/index.php?rid=2941011&cid=s_34061_13_f&fid=34061&url=http%3A%2F%2Fwww.biomedcentral.com%2Fcurropininvestigdrugs%2F No description available (Source: Current Opinion in Investigational Drugs) Current Opinion in Investigational Drugs journals http://www.medworm.com/rss/comments.php?id=2941011 Tue, 27 Oct 2009 00:00:00 +0100 2941011 Gene therapy approaches to induce tolerance in autoimmunity by reshaping the immune system http://www.medworm.com/index.php?rid=2941010&cid=s_34061_13_f&fid=34061&url=http%3A%2F%2Fwww.biomedcentral.com%2Fcurropininvestigdrugs%2F No description available (Source: Current Opinion in Investigational Drugs) Current Opinion in Investigational Drugs journals http://www.medworm.com/rss/comments.php?id=2941010 Tue, 27 Oct 2009 00:00:00 +0100 2941010 FLAP inhibitors for the treatment of inflammatory diseases http://www.medworm.com/index.php?rid=2941009&cid=s_34061_13_f&fid=34061&url=http%3A%2F%2Fwww.biomedcentral.com%2Fcurropininvestigdrugs%2F No description available (Source: Current Opinion in Investigational Drugs) Current Opinion in Investigational Drugs journals http://www.medworm.com/rss/comments.php?id=2941009 Tue, 27 Oct 2009 00:00:00 +0100 2941009 Modulation of inflammatory disease by inhibitors of leukotriene A4 hydrolase http://www.medworm.com/index.php?rid=2941008&cid=s_34061_13_f&fid=34061&url=http%3A%2F%2Fwww.biomedcentral.com%2Fcurropininvestigdrugs%2F No description available (Source: Current Opinion in Investigational Drugs) Current Opinion in Investigational Drugs journals http://www.medworm.com/rss/comments.php?id=2941008 Tue, 27 Oct 2009 00:00:00 +0100 2941008 Regulation of osteoclast precursors in inflammatory bone loss http://www.medworm.com/index.php?rid=2941007&cid=s_34061_13_f&fid=34061&url=http%3A%2F%2Fwww.biomedcentral.com%2Fcurropininvestigdrugs%2F No description available (Source: Current Opinion in Investigational Drugs) Current Opinion in Investigational Drugs journals http://www.medworm.com/rss/comments.php?id=2941007 Tue, 27 Oct 2009 00:00:00 +0100 2941007 Anti-cytokine antibodies for rheumatic diseases http://www.medworm.com/index.php?rid=2941006&cid=s_34061_13_f&fid=34061&url=http%3A%2F%2Fwww.biomedcentral.com%2Fcurropininvestigdrugs%2F No description available (Source: Current Opinion in Investigational Drugs) Current Opinion in Investigational Drugs journals http://www.medworm.com/rss/comments.php?id=2941006 Tue, 27 Oct 2009 00:00:00 +0100 2941006 AN-2728, a PDE4 inhibitor for the potential topical treatment of psoriasis and atopic dermatitis http://www.medworm.com/index.php?rid=2941005&cid=s_34061_13_f&fid=34061&url=http%3A%2F%2Fwww.biomedcentral.com%2Fcurropininvestigdrugs%2F No description available (Source: Current Opinion in Investigational Drugs) Current Opinion in Investigational Drugs journals http://www.medworm.com/rss/comments.php?id=2941005 Tue, 27 Oct 2009 00:00:00 +0100 2941005 Palovarotene, a novel retinoic acid receptor gamma agonist for the treatment of emphysema http://www.medworm.com/index.php?rid=2941004&cid=s_34061_13_f&fid=34061&url=http%3A%2F%2Fwww.biomedcentral.com%2Fcurropininvestigdrugs%2F No description available (Source: Current Opinion in Investigational Drugs) Current Opinion in Investigational Drugs journals http://www.medworm.com/rss/comments.php?id=2941004 Tue, 27 Oct 2009 00:00:00 +0100 2941004 Paper alert http://www.medworm.com/index.php?rid=2307641&cid=s_34061_13_f&fid=34061&url=http%3A%2F%2Fwww.biomedcentral.com%2F1472-4472%2F10%2F287 (Source: Current Opinion in Investigational Drugs) Current Opinion in Investigational Drugs journals http://www.medworm.com/rss/comments.php?id=2307641 Mon, 30 Mar 2009 04:00:00 +0100 2307641 Patent alert http://www.medworm.com/index.php?rid=2307640&cid=s_34061_13_f&fid=34061&url=http%3A%2F%2Fwww.biomedcentral.com%2F1472-4472%2F10%2F294 (Source: Current Opinion in Investigational Drugs) Current Opinion in Investigational Drugs journals http://www.medworm.com/rss/comments.php?id=2307640 Mon, 30 Mar 2009 04:00:00 +0100 2307640 The drugs from within http://www.medworm.com/index.php?rid=2307639&cid=s_34061_13_f&fid=34061&url=http%3A%2F%2Fwww.biomedcentral.com%2F1472-4472%2F10%2F303 (Source: Current Opinion in Investigational Drugs) Current Opinion in Investigational Drugs journals http://www.medworm.com/rss/comments.php?id=2307639 Mon, 30 Mar 2009 04:00:00 +0100 2307639 Endocannabinoids and reproductive endocrinology http://www.medworm.com/index.php?rid=2307638&cid=s_34061_13_f&fid=34061&url=http%3A%2F%2Fwww.biomedcentral.com%2F1472-4472%2F10%2F305 (Source: Current Opinion in Investigational Drugs) Current Opinion in Investigational Drugs journals http://www.medworm.com/rss/comments.php?id=2307638 Mon, 30 Mar 2009 04:00:00 +0100 2307638 Kisspeptin offers a novel therapeutic target in reproduction http://www.medworm.com/index.php?rid=2307637&cid=s_34061_13_f&fid=34061&url=http%3A%2F%2Fwww.biomedcentral.com%2F1472-4472%2F10%2F311 (Source: Current Opinion in Investigational Drugs) Current Opinion in Investigational Drugs journals http://www.medworm.com/rss/comments.php?id=2307637 Mon, 30 Mar 2009 04:00:00 +0100 2307637 Aldosterone synthase inhibitors: Pharmacological and clinical aspects http://www.medworm.com/index.php?rid=2307636&cid=s_34061_13_f&fid=34061&url=http%3A%2F%2Fwww.biomedcentral.com%2F1472-4472%2F10%2F319 (Source: Current Opinion in Investigational Drugs) Current Opinion in Investigational Drugs journals http://www.medworm.com/rss/comments.php?id=2307636 Mon, 30 Mar 2009 04:00:00 +0100 2307636 Treating diabetic retinopathy by inhibiting growth factor pathways http://www.medworm.com/index.php?rid=2307635&cid=s_34061_13_f&fid=34061&url=http%3A%2F%2Fwww.biomedcentral.com%2F1472-4472%2F10%2F327 (Source: Current Opinion in Investigational Drugs) Current Opinion in Investigational Drugs journals http://www.medworm.com/rss/comments.php?id=2307635 Mon, 30 Mar 2009 04:00:00 +0100 2307635 Engineered antibodies for type 1 diabetes http://www.medworm.com/index.php?rid=2307634&cid=s_34061_13_f&fid=34061&url=http%3A%2F%2Fwww.biomedcentral.com%2F1472-4472%2F10%2F336 (Source: Current Opinion in Investigational Drugs) Current Opinion in Investigational Drugs journals http://www.medworm.com/rss/comments.php?id=2307634 Mon, 30 Mar 2009 04:00:00 +0100 2307634 The adipocyte IKK/NFkappaB pathway: A therapeutic target for insulin resistance http://www.medworm.com/index.php?rid=2307633&cid=s_34061_13_f&fid=34061&url=http%3A%2F%2Fwww.biomedcentral.com%2F1472-4472%2F10%2F346 (Source: Current Opinion in Investigational Drugs) Current Opinion in Investigational Drugs journals http://www.medworm.com/rss/comments.php?id=2307633 Mon, 30 Mar 2009 04:00:00 +0100 2307633 4-Hydroxyisoleucine: A plant-derived treatment for metabolic syndrome http://www.medworm.com/index.php?rid=2307632&cid=s_34061_13_f&fid=34061&url=http%3A%2F%2Fwww.biomedcentral.com%2F1472-4472%2F10%2F353 (Source: Current Opinion in Investigational Drugs) Current Opinion in Investigational Drugs journals http://www.medworm.com/rss/comments.php?id=2307632 Mon, 30 Mar 2009 04:00:00 +0100 2307632 FGF21: A novel prospect for the treatment of metabolic diseases http://www.medworm.com/index.php?rid=2307631&cid=s_34061_13_f&fid=34061&url=http%3A%2F%2Fwww.biomedcentral.com%2F1472-4472%2F10%2F359 (Source: Current Opinion in Investigational Drugs) Current Opinion in Investigational Drugs journals http://www.medworm.com/rss/comments.php?id=2307631 Mon, 30 Mar 2009 04:00:00 +0100 2307631 MF-101, an estrogen receptor beta agonist for the treatment of vasomotor symptoms in peri- and postmenopausal women http://www.medworm.com/index.php?rid=2307630&cid=s_34061_13_f&fid=34061&url=http%3A%2F%2Fwww.biomedcentral.com%2F1472-4472%2F10%2F365 (Source: Current Opinion in Investigational Drugs) Current Opinion in Investigational Drugs journals http://www.medworm.com/rss/comments.php?id=2307630 Mon, 30 Mar 2009 04:00:00 +0100 2307630 Corifollitropin alfa, a long-acting follicle-stimulating hormone agonist for the treatment of infertility http://www.medworm.com/index.php?rid=2307629&cid=s_34061_13_f&fid=34061&url=http%3A%2F%2Fwww.biomedcentral.com%2F1472-4472%2F10%2F372 (Source: Current Opinion in Investigational Drugs) Current Opinion in Investigational Drugs journals http://www.medworm.com/rss/comments.php?id=2307629 Mon, 30 Mar 2009 04:00:00 +0100 2307629 INT-131, a PPARgamma agonist for the treatment of type 2 diabetes http://www.medworm.com/index.php?rid=2307628&cid=s_34061_13_f&fid=34061&url=http%3A%2F%2Fwww.biomedcentral.com%2F1472-4472%2F10%2F381 (Source: Current Opinion in Investigational Drugs) Current Opinion in Investigational Drugs journals http://www.medworm.com/rss/comments.php?id=2307628 Mon, 30 Mar 2009 04:00:00 +0100 2307628 Paper alert http://www.medworm.com/index.php?rid=2264106&cid=s_34061_13_f&fid=34061&url=http%3A%2F%2Fwww.biomedcentral.com%2F1472-4472%2F10%2F201 (Source: Current Opinion in Investigational Drugs) Current Opinion in Investigational Drugs journals http://www.medworm.com/rss/comments.php?id=2264106 Mon, 02 Mar 2009 05:00:00 +0100 2264106 Patent alert http://www.medworm.com/index.php?rid=2264105&cid=s_34061_13_f&fid=34061&url=http%3A%2F%2Fwww.biomedcentral.com%2F1472-4472%2F10%2F209 (Source: Current Opinion in Investigational Drugs) Current Opinion in Investigational Drugs journals http://www.medworm.com/rss/comments.php?id=2264105 Mon, 02 Mar 2009 05:00:00 +0100 2264105 Drug development research: Diabetes favored over cardiovascular disease? http://www.medworm.com/index.php?rid=2264104&cid=s_34061_13_f&fid=34061&url=http%3A%2F%2Fwww.biomedcentral.com%2F1472-4472%2F10%2F217 (Source: Current Opinion in Investigational Drugs) Current Opinion in Investigational Drugs journals http://www.medworm.com/rss/comments.php?id=2264104 Mon, 02 Mar 2009 05:00:00 +0100 2264104 Ischemic stroke intervention requires mixed cellular protection of the penumbra http://www.medworm.com/index.php?rid=2264103&cid=s_34061_13_f&fid=34061&url=http%3A%2F%2Fwww.biomedcentral.com%2F1472-4472%2F10%2F220 (Source: Current Opinion in Investigational Drugs) Current Opinion in Investigational Drugs journals http://www.medworm.com/rss/comments.php?id=2264103 Mon, 02 Mar 2009 05:00:00 +0100 2264103 The use of lipid-lowering drug therapy in children and adolescents http://www.medworm.com/index.php?rid=2264102&cid=s_34061_13_f&fid=34061&url=http%3A%2F%2Fwww.biomedcentral.com%2F1472-4472%2F10%2F224 (Source: Current Opinion in Investigational Drugs) Current Opinion in Investigational Drugs journals http://www.medworm.com/rss/comments.php?id=2264102 Mon, 02 Mar 2009 05:00:00 +0100 2264102 The role of a murine transplantation model of atherosclerosis regression in drug discovery http://www.medworm.com/index.php?rid=2264101&cid=s_34061_13_f&fid=34061&url=http%3A%2F%2Fwww.biomedcentral.com%2F1472-4472%2F10%2F232 (Source: Current Opinion in Investigational Drugs) Current Opinion in Investigational Drugs journals http://www.medworm.com/rss/comments.php?id=2264101 Mon, 02 Mar 2009 05:00:00 +0100 2264101 Reassessing the validity of surrogate markers of drug efficacy in the treatment of coronary artery disease http://www.medworm.com/index.php?rid=2264100&cid=s_34061_13_f&fid=34061&url=http%3A%2F%2Fwww.biomedcentral.com%2F1472-4472%2F10%2F239 (Source: Current Opinion in Investigational Drugs) Current Opinion in Investigational Drugs journals http://www.medworm.com/rss/comments.php?id=2264100 Mon, 02 Mar 2009 05:00:00 +0100 2264100 'Muscle-sparing' statins: Preclinical profiles and future clinical use http://www.medworm.com/index.php?rid=2264099&cid=s_34061_13_f&fid=34061&url=http%3A%2F%2Fwww.biomedcentral.com%2F1472-4472%2F10%2F245 (Source: Current Opinion in Investigational Drugs) Current Opinion in Investigational Drugs journals http://www.medworm.com/rss/comments.php?id=2264099 Mon, 02 Mar 2009 05:00:00 +0100 2264099 Soluble epoxide hydrolase: A new target for cardioprotection http://www.medworm.com/index.php?rid=2264098&cid=s_34061_13_f&fid=34061&url=http%3A%2F%2Fwww.biomedcentral.com%2F1472-4472%2F10%2F253 (Source: Current Opinion in Investigational Drugs) Current Opinion in Investigational Drugs journals http://www.medworm.com/rss/comments.php?id=2264098 Mon, 02 Mar 2009 05:00:00 +0100 2264098 NV1FGF, a pCOR plasmid-based angiogenic gene therapy for the treatment of intermittent claudication and critical limb ischemia http://www.medworm.com/index.php?rid=2264097&cid=s_34061_13_f&fid=34061&url=http%3A%2F%2Fwww.biomedcentral.com%2F1472-4472%2F10%2F259 (Source: Current Opinion in Investigational Drugs) Current Opinion in Investigational Drugs journals http://www.medworm.com/rss/comments.php?id=2264097 Mon, 02 Mar 2009 05:00:00 +0100 2264097 CYT-006-AngQb, a vaccine against angiotensin II for the potential treatment of hypertension http://www.medworm.com/index.php?rid=2264096&cid=s_34061_13_f&fid=34061&url=http%3A%2F%2Fwww.biomedcentral.com%2F1472-4472%2F10%2F269 (Source: Current Opinion in Investigational Drugs) Current Opinion in Investigational Drugs journals http://www.medworm.com/rss/comments.php?id=2264096 Mon, 02 Mar 2009 05:00:00 +0100 2264096 LA-419, a nitric-oxide donor for the treatment of cardiovascular disorders http://www.medworm.com/index.php?rid=2264095&cid=s_34061_13_f&fid=34061&url=http%3A%2F%2Fwww.biomedcentral.com%2F1472-4472%2F10%2F276 (Source: Current Opinion in Investigational Drugs) Current Opinion in Investigational Drugs journals http://www.medworm.com/rss/comments.php?id=2264095 Mon, 02 Mar 2009 05:00:00 +0100 2264095 Paper alert http://www.medworm.com/index.php?rid=2163409&cid=s_34061_13_f&fid=34061&url=http%3A%2F%2Fwww.biomedcentral.com%2F1472-4472%2F10%2F103 (Source: Current Opinion in Investigational Drugs) Current Opinion in Investigational Drugs journals http://www.medworm.com/rss/comments.php?id=2163409 Tue, 03 Feb 2009 05:00:00 +0100 2163409 Patent alert http://www.medworm.com/index.php?rid=2163408&cid=s_34061_13_f&fid=34061&url=http%3A%2F%2Fwww.biomedcentral.com%2F1472-4472%2F10%2F109 (Source: Current Opinion in Investigational Drugs) Current Opinion in Investigational Drugs journals http://www.medworm.com/rss/comments.php?id=2163408 Tue, 03 Feb 2009 05:00:00 +0100 2163408 Old drugs resurrected? http://www.medworm.com/index.php?rid=2163407&cid=s_34061_13_f&fid=34061&url=http%3A%2F%2Fwww.biomedcentral.com%2F1472-4472%2F10%2F119 (Source: Current Opinion in Investigational Drugs) Current Opinion in Investigational Drugs journals http://www.medworm.com/rss/comments.php?id=2163407 Tue, 03 Feb 2009 05:00:00 +0100 2163407 Ribosomal frameshifting: An emerging drug target for HIV http://www.medworm.com/index.php?rid=2163406&cid=s_34061_13_f&fid=34061&url=http%3A%2F%2Fwww.biomedcentral.com%2F1472-4472%2F10%2F121 (Source: Current Opinion in Investigational Drugs) Current Opinion in Investigational Drugs journals http://www.medworm.com/rss/comments.php?id=2163406 Tue, 03 Feb 2009 05:00:00 +0100 2163406 New approaches for inhibiting HIV integrase: A journey beyond the active site http://www.medworm.com/index.php?rid=2163405&cid=s_34061_13_f&fid=34061&url=http%3A%2F%2Fwww.biomedcentral.com%2F1472-4472%2F10%2F129 (Source: Current Opinion in Investigational Drugs) Current Opinion in Investigational Drugs journals http://www.medworm.com/rss/comments.php?id=2163405 Tue, 03 Feb 2009 05:00:00 +0100 2163405 Current developments in anti-HIV/AIDS gene therapy http://www.medworm.com/index.php?rid=2163404&cid=s_34061_13_f&fid=34061&url=http%3A%2F%2Fwww.biomedcentral.com%2F1472-4472%2F10%2F137 No abstract available (Source: Current Opinion in Investigational Drugs) Current Opinion in Investigational Drugs journals http://www.medworm.com/rss/comments.php?id=2163404 Tue, 03 Feb 2009 05:00:00 +0100 2163404 Treatment of multiresistant Acinetobacter baumannii infections http://www.medworm.com/index.php?rid=2163403&cid=s_34061_13_f&fid=34061&url=http%3A%2F%2Fwww.biomedcentral.com%2F1472-4472%2F10%2F150 (Source: Current Opinion in Investigational Drugs) Current Opinion in Investigational Drugs journals http://www.medworm.com/rss/comments.php?id=2163403 Tue, 03 Feb 2009 05:00:00 +0100 2163403 Challenges in developing new antibacterial drugs http://www.medworm.com/index.php?rid=2163402&cid=s_34061_13_f&fid=34061&url=http%3A%2F%2Fwww.biomedcentral.com%2F1472-4472%2F10%2F157 (Source: Current Opinion in Investigational Drugs) Current Opinion in Investigational Drugs journals http://www.medworm.com/rss/comments.php?id=2163402 Tue, 03 Feb 2009 05:00:00 +0100 2163402 Host defense peptides for use as potential therapeutics http://www.medworm.com/index.php?rid=2163401&cid=s_34061_13_f&fid=34061&url=http%3A%2F%2Fwww.biomedcentral.com%2F1472-4472%2F10%2F164 (Source: Current Opinion in Investigational Drugs) Current Opinion in Investigational Drugs journals http://www.medworm.com/rss/comments.php?id=2163401 Tue, 03 Feb 2009 05:00:00 +0100 2163401 Addressing the challenge of extended-spectrum beta-lactamases http://www.medworm.com/index.php?rid=2163400&cid=s_34061_13_f&fid=34061&url=http%3A%2F%2Fwww.biomedcentral.com%2F1472-4472%2F10%2F172 (Source: Current Opinion in Investigational Drugs) Current Opinion in Investigational Drugs journals http://www.medworm.com/rss/comments.php?id=2163400 Tue, 03 Feb 2009 05:00:00 +0100 2163400 Boceprevir, an NS3 serine protease inhibitor of hepatitis C virus, for the treatment of HCV infection http://www.medworm.com/index.php?rid=2163399&cid=s_34061_13_f&fid=34061&url=http%3A%2F%2Fwww.biomedcentral.com%2F1472-4472%2F10%2F181 (Source: Current Opinion in Investigational Drugs) Current Opinion in Investigational Drugs journals http://www.medworm.com/rss/comments.php?id=2163399 Tue, 03 Feb 2009 05:00:00 +0100 2163399 Elvitegravir, an oral HIV integrase inhibitor, for the potential treatment of HIV infection http://www.medworm.com/index.php?rid=2163398&cid=s_34061_13_f&fid=34061&url=http%3A%2F%2Fwww.biomedcentral.com%2F1472-4472%2F10%2F190 (Source: Current Opinion in Investigational Drugs) Current Opinion in Investigational Drugs journals http://www.medworm.com/rss/comments.php?id=2163398 Tue, 03 Feb 2009 05:00:00 +0100 2163398 Paper alert http://www.medworm.com/index.php?rid=2107438&cid=s_34061_13_f&fid=34061&url=http%3A%2F%2Fwww.biomedcentral.com%2F1472-4472%2F10%2F1 (Source: Current Opinion in Investigational Drugs) Current Opinion in Investigational Drugs journals http://www.medworm.com/rss/comments.php?id=2107438 Tue, 23 Dec 2008 05:00:00 +0100 2107438 Patent alert http://www.medworm.com/index.php?rid=2107437&cid=s_34061_13_f&fid=34061&url=http%3A%2F%2Fwww.biomedcentral.com%2F1472-4472%2F10%2F9 (Source: Current Opinion in Investigational Drugs) Current Opinion in Investigational Drugs journals http://www.medworm.com/rss/comments.php?id=2107437 Tue, 23 Dec 2008 05:00:00 +0100 2107437 Is urological research stalled or stopped? http://www.medworm.com/index.php?rid=2107436&cid=s_34061_13_f&fid=34061&url=http%3A%2F%2Fwww.biomedcentral.com%2F1472-4472%2F10%2F20 (Source: Current Opinion in Investigational Drugs) Current Opinion in Investigational Drugs journals http://www.medworm.com/rss/comments.php?id=2107436 Tue, 23 Dec 2008 05:00:00 +0100 2107436 Progress in Alzheimer's disease drug discovery: An update http://www.medworm.com/index.php?rid=2107435&cid=s_34061_13_f&fid=34061&url=http%3A%2F%2Fwww.biomedcentral.com%2F1472-4472%2F10%2F23 (Source: Current Opinion in Investigational Drugs) Current Opinion in Investigational Drugs journals http://www.medworm.com/rss/comments.php?id=2107435 Tue, 23 Dec 2008 05:00:00 +0100 2107435 Pharmacotherapy in post-traumatic stress disorder: Evidence from randomized controlled trials http://www.medworm.com/index.php?rid=2107434&cid=s_34061_13_f&fid=34061&url=http%3A%2F%2Fwww.biomedcentral.com%2F1472-4472%2F10%2F35 (Source: Current Opinion in Investigational Drugs) Current Opinion in Investigational Drugs journals http://www.medworm.com/rss/comments.php?id=2107434 Tue, 23 Dec 2008 05:00:00 +0100 2107434 Endothelial dysfunction: A potential therapeutic target for geriatric depression and brain amyloid deposition in Alzheimer's disease? http://www.medworm.com/index.php?rid=2107433&cid=s_34061_13_f&fid=34061&url=http%3A%2F%2Fwww.biomedcentral.com%2F1472-4472%2F10%2F46 (Source: Current Opinion in Investigational Drugs) Current Opinion in Investigational Drugs journals http://www.medworm.com/rss/comments.php?id=2107433 Tue, 23 Dec 2008 05:00:00 +0100 2107433 The manipulation of cation-chloride co-transporters as a novel means to treat persistent pain, epilepsy and other neurological disorders http://www.medworm.com/index.php?rid=2107432&cid=s_34061_13_f&fid=34061&url=http%3A%2F%2Fwww.biomedcentral.com%2F1472-4472%2F10%2F56 (Source: Current Opinion in Investigational Drugs) Current Opinion in Investigational Drugs journals http://www.medworm.com/rss/comments.php?id=2107432 Tue, 23 Dec 2008 05:00:00 +0100 2107432 The pharmacological mechanisms of electroacupuncture http://www.medworm.com/index.php?rid=2107431&cid=s_34061_13_f&fid=34061&url=http%3A%2F%2Fwww.biomedcentral.com%2F1472-4472%2F10%2F62 (Source: Current Opinion in Investigational Drugs) Current Opinion in Investigational Drugs journals http://www.medworm.com/rss/comments.php?id=2107431 Tue, 23 Dec 2008 05:00:00 +0100 2107431 The relationship between dysglycemia and cognitive dysfunction http://www.medworm.com/index.php?rid=2107430&cid=s_34061_13_f&fid=34061&url=http%3A%2F%2Fwww.biomedcentral.com%2F1472-4472%2F10%2F70 (Source: Current Opinion in Investigational Drugs) Current Opinion in Investigational Drugs journals http://www.medworm.com/rss/comments.php?id=2107430 Tue, 23 Dec 2008 05:00:00 +0100 2107430 Desvenlafaxine, a serotonin-norepinephrine uptake inhibitor for major depressive disorder, neuropathic pain and the vasomotor symptoms associated with menopause http://www.medworm.com/index.php?rid=2107429&cid=s_34061_13_f&fid=34061&url=http%3A%2F%2Fwww.biomedcentral.com%2F1472-4472%2F10%2F75 (Source: Current Opinion in Investigational Drugs) Current Opinion in Investigational Drugs journals http://www.medworm.com/rss/comments.php?id=2107429 Tue, 23 Dec 2008 05:00:00 +0100 2107429 Gabapentin enacarbil, a gabapentin prodrug for the treatment of the neurological symptoms associated with disorders such as restless legs syndrome http://www.medworm.com/index.php?rid=2107428&cid=s_34061_13_f&fid=34061&url=http%3A%2F%2Fwww.biomedcentral.com%2F1472-4472%2F10%2F91 (Source: Current Opinion in Investigational Drugs) Current Opinion in Investigational Drugs journals http://www.medworm.com/rss/comments.php?id=2107428 Tue, 23 Dec 2008 05:00:00 +0100 2107428 Paper alert http://www.medworm.com/index.php?rid=2039377&cid=s_34061_13_f&fid=34061&url=http%3A%2F%2Fwww.biomedcentral.com%2F1472-4472%2F9%2F1239 (Source: Current Opinion in Investigational Drugs) Current Opinion in Investigational Drugs journals http://www.medworm.com/rss/comments.php?id=2039377 Tue, 25 Nov 2008 05:00:00 +0100 2039377 Patent alert http://www.medworm.com/index.php?rid=2039376&cid=s_34061_13_f&fid=34061&url=http%3A%2F%2Fwww.biomedcentral.com%2F1472-4472%2F9%2F1247 (Source: Current Opinion in Investigational Drugs) Current Opinion in Investigational Drugs journals http://www.medworm.com/rss/comments.php?id=2039376 Tue, 25 Nov 2008 05:00:00 +0100 2039376